Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wisconsin Business Press.
Press releases published on September 30, 2025
SLP Investor News: If You Have Suffered Losses in Simulations Plus, Inc. (NASDAQ: SLP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Simulations Plus, Inc. (NASDAQ: SLP) resulting from allegations that …
MARTEN TRANSPORT CLOSES ON THE SALE OF ASSETS RELATED TO INTERMODAL BUSINESS
MONDOVI, Wis., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Marten Transport, Ltd. (Nasdaq/GS:MRTN) closed on the previously announced agreement to sell assets related to its intermodal business to Hub Group, Inc. (NASDAQ: HUBG), effective September 30, 2025. The …
Hub Group Closes on the Acquisition of Marten Transport Intermodal
OAK BROOK, Ill., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Effective September 30, 2025, Hub Group, Inc. (NASDAQ: HUBG) closed on the previously announced acquisition of certain assets of Marten Transport, Ltd. Intermodal (“Marten Intermodal”), a division of …
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Fraud Lawsuit – UNCY
NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Unicycive Therapeutics, Inc. (NASDAQ: UNCY) between March 29, 2024 and June 27, 2025, both dates inclusive (the “Class …
YD Bio Limited Reports Unaudited Half Year 2025 Financial Results
TAIWAN, Sept. 30, 2025 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio Ltd” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations, today announced its unaudited …
KPJ Healthcare Bermitra dengan NetSfere untuk Meningkatkan Komunikasi Aman di 30 Rumah Sakit
KUALA LUMPUR, Malaysia, Oct. 01, 2025 (GLOBE NEWSWIRE) -- KPJ Healthcare Berhad (“KPJ Healthcare”), penyedia layanan kesehatan swasta terbesar di Malaysia, telah menjalin kemitraan strategis dengan NetSfere, penyedia global untuk perpesanan perusahaan yang …
KPJ Healthcare Bekerjasama dengan NetSfere untuk Mempertingkatkan Keselamatan Komunikasi di 30 hospital
KUALA LUMPUR, Malaysia, Oct. 01, 2025 (GLOBE NEWSWIRE) -- KPJ Healthcare Berhad (“KPJ Healthcare”), penyedia penjagaan kesihatan swasta terbesar di Malaysia, telah menjalin kerjasama strategik dengan NetSfere, penyedia global bagi penyelesaian pemesejan …
KPJ Healthcare hợp tác với NetSfere để tăng cường giao tiếp an toàn khắp 30 bệnh viện
KUALA LUMPUR, Malaysia, Oct. 01, 2025 (GLOBE NEWSWIRE) -- KPJ Healthcare Berhad (“KPJ Healthcare”), nhà cung cấp dịch vụ chăm sóc sức khỏe tư nhân lớn nhất Malaysia, đã ký kết quan hệ đối tác chiến lược với NetSfere, nhà cung cấp giải pháp nhắn tin và cộng …
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Charter Communications, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CHTR
NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities (as well as purchasers of call options or sellers of put options) of Charter Communications, Inc. (NASDAQ: CHTR) between …
Coherent Honored at ECOC 2025 With Industry Recognition for Optical Innovation
SAXONBURG, Pa., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR), a global leader in photonics, proudly announced today that it has been recognized with two awards at ECOC 2025, Europe’s largest optical communications exhibition. The honors …
ADT Announces Pricing of First-Priority Senior Secured Notes
BOCA RATON, Fla., Sept. 30, 2025 (GLOBE NEWSWIRE) -- ADT Inc. (NYSE: ADT) (the “Company” or “ADT”), today announced that its indirect wholly owned subsidiary, The ADT Security Corporation, has priced its offering of $1.0 billion aggregate principal amount …
MoonLake Immunotherapeutics (MLTX) Faces Investor Scrutiny After Reporting Disappointing Phase 3 Trial Data For Lead Drug Candidate -- Hagens Berman
SAN FRANCISCO, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Investors in MoonLake Immunotherapeutics (NASDAQ: MLTX) saw the price of their shares crater $55.75, or about 90%, after the company announced disastrous VELA-2 trial results for sonelokimab, its highly …